Can measurement of B-type natriuretic peptide levels improve cardiovascular disease prevention?

被引：17

作者：

Campbell, Duncan J. ^{[1
,2
]}

机构：

[1] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia

[2] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia

来源：

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 2008年 / 35卷 / 04期

关键词：

amino-terminal pro-BNP (NT-proBNP); atrial fibrillation; B-type natriuretic peptide (BNP); cardiovascular disease; heart failure; myocardial infarction; risk factor; stroke;

D O I：

10.1111/j.1440-1681.2008.04894.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

1. The measurement of plasma levels of B-type natriuretic peptide (BNP) and amino-terminal pro-BNP (NT-proBNP) provides useful diagnostic information in patients with suspected heart failure and valuable prognostic information in patients with heart failure, acute coronary syndrome, valvular heart disease and other cardiac pathologies. 2. BNP- and NT-proBNP-guided heart failure therapy improves patient outcomes. 3. An increasing number of studies shows plasma BNP and NT-proBNP levels predict all-cause mortality and cardiovascular events including heart failure, myocardial infarction, stroke, atrial fibrillation and cardiovascular death in stable patients with or without known cardiovascular disease and provide information about cardiovascular risk additional to that provided by traditional risk factors. 4. Anti hypertensive therapy reduces elevated NT-proBNP levels in individuals at increased cardiovascular risk, thereby suggesting that change in NT-proBNP levels provides a measure of risk reduction. 5. Thus, monitoring of BNP and NT-proBNP levels offers the possibilities of improved targeting of individuals with increased cardiovascular risk and optimization of strategies for primary and secondary prevention of cardiovascular disease. 6. There is need for an outcome study to determine whether BNP- or NT-proBNP-guided therapy improves cardiovascular disease prevention.

引用

页码：442 / 446

页数：5

共 59 条

[41] N-terminal pro-brain natriuretic peptide in arterial hypertension: A valuable prognostic marker of cardiovascular events [J].

Pedersen, F ;

Raymond, I ;

Kistorp, C ;

Sandgaard, N ;

Jacobsen, P ;

Hildebrandt, P .

JOURNAL OF CARDIAC FAILURE, 2005, 11 (05) :S70-S75

[42]

PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556, DOI 10.1016/S0140-6736(01)06178-5

[43] Cardiac natriuretic peptides for cardiac health [J].

Rademaker, MT ;

Richards, AM .

CLINICAL SCIENCE, 2005, 108 (01) :23-36

[44] Burden of systolic and diastolic ventricular dysfunction in the community - Appreciating the scope of the heart failure epidemic [J].

Redfield, MM ;

Jacobsen, SJ ;

Burnett, JC ;

Mahoney, DW ;

Bailey, KR ;

Rodeheffer, RJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (02) :194-202

[45] Natriuretic peptides - Update on peptide release, bioactivity, and clinical use [J].

Richards, A. Mark .

HYPERTENSION, 2007, 50 (01) :25-30

[46] Development and validation of improved algorithms for the assessment of global cardiovascular risk in women - The Reynolds Risk Score [J].

Ridker, Paul M. ;

Buring, Julie E. ;

Rifai, Nader ;

Cook, Nancy R. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (06) :611-619

[47] Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease [J].

Rothenbacher, Dietrich ;

Koenig, Wolfgang ;

Brenner, Hermann .

ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (22) :2455-2460

[48] B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina -: Results from the AtheroGene study [J].

Schnabel, R ;

Lubos, E ;

Rupprecht, HJ ;

Espinola-Klein, C ;

Bickel, C ;

Lackner, KJ ;

Cambien, F ;

Tiret, L ;

Münzel, T ;

Blankenberg, S .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (03) :552-558

[49] Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease:: results from the AtheroGene study [J].

Schnabel, R ;

Rupprecht, HJ ;

Lackner, KJ ;

Lubos, E ;

Bickel, C ;

Meyer, J ;

Münzel, T ;

Cambien, F ;

Tiret, L ;

Blankenberg, S .

EUROPEAN HEART JOURNAL, 2005, 26 (03) :241-249

[50] Prognostic value of high plasma brain natriuretic peptide concentration's in very elderly persons [J].

Ueda, R ;

Yokouchi, M ;

Suzuki, T ;

Otomo, E ;

Katagiri, T .

AMERICAN JOURNAL OF MEDICINE, 2003, 114 (04) :266-270

← 1 2 3 4 5 6 →